MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6503-685-691$20.00
Mol Pharmacol 65:685-691, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leipold, E.
Right arrow Articles by Heinemann, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leipold, E.
Right arrow Articles by Heinemann, S. H.

Combinatorial Interaction of Scorpion Toxins Lqh-2, Lqh-3, and Lqh{alpha}IT with Sodium Channel Receptor Sites-3

Enrico Leipold, Songqing Lu, Dalia Gordon, Alfred Hansel, and Stefan H. Heinemann

Research Unit "Molecular and Cellular Biophysics", Medical Faculty of the Friedrich Schiller University Jena, Jena, Germany (E.L., S.L., A.H., S.H.H.); and Department of Plant Sciences, Tel Aviv University, Tel Aviv, Israel (D.G.)

Scorpion {alpha}-toxins Lqh{alpha}IT, Lqh-2, and Lqh-3 are representatives of three groups of {alpha}-toxins that differ in their preference for insects and mammals. These {alpha}-insect, antimammalian, and {alpha}-like toxins bind to voltage-gated sodium channels and slow down channel inactivation. Sodium channel mutagenesis studies using various {alpha}-toxins have shown that they interact with receptor site 3, which is composed mainly of a short stretch of amino-acid residues between S3 and S4 of domain 4. Variation in this region results in marked differences between various subtypes of sodium channels with respect to their sensitivity to the three Lqh toxins. We incorporated the S3-S4 linker of domain 4 from hNaV1.2/hNaV1.1, hNaV1.3, hNaV1.6, and hNaV1.7 channels as well as individual point mutations into the rNaV1.4 skeletal muscle sodium channel. Our data show that the affinity of Lqh-3 and Lqh{alpha}IT to sodium channels is markedly determined by an aspartate residue (Asp1428 in rNaV1.4); when mutated to glutamate, as is present in NaV1.1–1.3 channels, Lqh-3–channel interactions are abolished. The interaction of Lqh-2 and Lqh{alpha}IT, however, is strongly reduced when a lysine residue (Lys1432 in rNaV1.4) is replaced by threonine (as in hNaV1.7), whereas this substitution is without effect for Lqh-3. The influence of Lys1432 on Lqh-2 and Lqh{alpha}IT strongly depends on the context of the Asp/Glu site at position 1428, giving rise to a wide variety of toxicological phenotypes by means of a combinatorial mixing and matching of only a few residues in receptor site 3.


Received September 15, 2003; accepted December 3, 2003

Address correspondence to: Prof. Dr. Stefan H. Heinemann, Molecular and Cellular Biophysics, Friedrich Schiller University Jena, Drackendorfer Str. 1, D-07747 Jena, Germany. E-mail: stefan.h.heinemann{at}uni-jena.de




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. Cohen, Y. Troub, M. Turkov, N. Gilles, N. Ilan, M. Benveniste, D. Gordon, and M. Gurevitz
Mammalian Skeletal Muscle Voltage-Gated Sodium Channels Are Affected by Scorpion Depressant "Insect-Selective" Toxins when Preconditioned
Mol. Pharmacol., November 1, 2007; 72(5): 1220 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Cohen, N. Gilles, I. Karbat, N. Ilan, D. Gordon, and M. Gurevitz
Direct Evidence That Receptor Site-4 of Sodium Channel Gating Modifiers Is Not Dipped in the Phospholipid Bilayer of Neuronal Membranes
J. Biol. Chem., July 28, 2006; 281(30): 20673 - 20679.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
W. Ulbricht
Sodium Channel Inactivation: Molecular Determinants and Modulation
Physiol Rev, October 1, 2005; 85(4): 1271 - 1301.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics